U
Better Therapeutics, Inc. BTTX
$0.0002 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -14.34% 10.49% 42.80% 96.19% 266.76%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -29.57% -11.92% 2.50% 25.20% 110.49%
Operating Income 29.57% 11.92% -2.50% -25.20% -110.49%
Income Before Tax 29.68% 19.24% 11.69% 1.82% -58.84%
Income Tax Expenses -- 400.00% 500.00% 104.58% 100.00%
Earnings from Continuing Operations 29.66% 19.22% 11.67% 1.43% -59.23%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 29.66% 19.22% 11.67% 1.43% -59.23%
EBIT 29.57% 11.92% -2.50% -25.20% -110.49%
EBITDA 32.00% 13.54% -1.56% -22.98% -111.80%
EPS Basic 40.97% 44.45% 46.28% 47.70% 26.33%
Normalized Basic EPS 42.75% 44.93% 47.08% 48.10% 22.46%
EPS Diluted 40.97% 44.45% 46.28% 47.70% 26.33%
Normalized Diluted EPS 42.75% 44.93% 47.08% 48.10% 22.46%
Average Basic Shares Outstanding 29.76% 32.33% 46.88% 82.13% 59.20%
Average Diluted Shares Outstanding 29.76% 32.33% 46.88% 82.13% 59.20%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings